Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Strohfeldt

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Chemical Society Reviews|May 24, 2008
Bioorganometallic fulvene-derived titanocene anti-cancer drugsKatja Strohfeldt, Matthias Tacke
American Journal of Pharmaceutical Education|February 4, 2016
Using Problem-Based Learning in a Chemistry Practical Class for Pharmacy Students and Engaging Them with FeedbackKatja Strohfeldt, Olga Khutoryanskaya
American Journal of Pharmaceutical Education|February 9, 2011
A model for self-directed problem-based learning for renal therapeuticsKatja Strohfeldt, Daniel T Grant
Journal of the American Chemical Society|November 6, 2003
The crystal structures of the chiral alkyllithium bases [n-BuLi.(-)-sparteine]2 and [Et2O.(i-PrLi)2.(-)-sparteine]Carsten Strohmann, Katja Strohfeldt, Daniel Schildbach
Angewandte Chemie (International Ed. in English)|October 2, 2003
[tBuLi.(-)-sparteine]: molecular structure of the first monomeric butyllithium compoundCarsten Strohmann, Timo Seibel, Katja Strohfeldt
European Journal of Medicinal Chemistry|April 7, 2007
Synthesis and cytotoxicity studies of new dimethylamino-functionalised and aryl-substituted titanocene anti-cancer agentsClara Pampillón, James Claffey, Katja Strohfeldt, et al.
Metallomics : Integrated Biometal Science|January 7, 2011
Titanocene anticancer complexes and their binding mode of action to human serum albumin: a computational studySusan W Sarsam, David R Nutt, Katja Strohfeldt, et al.
Anti-Cancer Drugs|March 8, 2006
Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in miceIduna Fichtner, Clara Pampillón, Nigel J Sweeney, et al.
Anti-Cancer Drugs|October 14, 2005
In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenesGerhard Kelter, Nigel J Sweeney, Katja Strohfeldt, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 30, 2010
Silyl-modified analogues of 2-tritylpyrrolidine: synthesis and applications in asymmetric organocatalysisJonathan O Bauer, Julian Stiller, Eugenia Marqués-López, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Chemical Society Reviews|May 24, 2008
Bioorganometallic fulvene-derived titanocene anti-cancer drugsKatja Strohfeldt, Matthias Tacke
American Journal of Pharmaceutical Education|February 4, 2016
Using Problem-Based Learning in a Chemistry Practical Class for Pharmacy Students and Engaging Them with FeedbackKatja Strohfeldt, Olga Khutoryanskaya
American Journal of Pharmaceutical Education|February 9, 2011
A model for self-directed problem-based learning for renal therapeuticsKatja Strohfeldt, Daniel T Grant
Journal of the American Chemical Society|November 6, 2003
The crystal structures of the chiral alkyllithium bases [n-BuLi.(-)-sparteine]2 and [Et2O.(i-PrLi)2.(-)-sparteine]Carsten Strohmann, Katja Strohfeldt, Daniel Schildbach
Angewandte Chemie (International Ed. in English)|October 2, 2003
[tBuLi.(-)-sparteine]: molecular structure of the first monomeric butyllithium compoundCarsten Strohmann, Timo Seibel, Katja Strohfeldt
European Journal of Medicinal Chemistry|April 7, 2007
Synthesis and cytotoxicity studies of new dimethylamino-functionalised and aryl-substituted titanocene anti-cancer agentsClara Pampillón, James Claffey, Katja Strohfeldt, et al.
Metallomics : Integrated Biometal Science|January 7, 2011
Titanocene anticancer complexes and their binding mode of action to human serum albumin: a computational studySusan W Sarsam, David R Nutt, Katja Strohfeldt, et al.
Anti-Cancer Drugs|March 8, 2006
Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in miceIduna Fichtner, Clara Pampillón, Nigel J Sweeney, et al.
Anti-Cancer Drugs|October 14, 2005
In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenesGerhard Kelter, Nigel J Sweeney, Katja Strohfeldt, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 30, 2010
Silyl-modified analogues of 2-tritylpyrrolidine: synthesis and applications in asymmetric organocatalysisJonathan O Bauer, Julian Stiller, Eugenia Marqués-López, et al.
Pageof 2